title: Erratum to: The optimal regimen of bevacizumab for recurrent glioblastoma: does dose matter?
authors.affiliation: Neuro-Oncology Service, Division of Oncology, Tel-Aviv Sourasky Medical Center, 6 Weizmann St., 64239, Tel-Aviv, Israel. deborahblumenthal@gmail.com.
authors.forename: D T
authors.initials: DT
authors.lastname: Blumenthal
authors.affiliation: Omnistat Statistical Consulting, Tel-Aviv, Israel.
authors.forename: L
authors.initials: L
authors.lastname: Mendel
authors.affiliation: Neuro-Oncology Service, Division of Oncology, Tel-Aviv Sourasky Medical Center, 6 Weizmann St., 64239, Tel-Aviv, Israel.
authors.forename: F
authors.initials: F
authors.lastname: Bokstein